APA (7th ed.) Citation

Halilbasic, E., Fuerst, E., Heiden, D., Japtok, L., Diesner, S., Hillebrand, P., . . . Untersmayr, E. (2017). EPS3.3 Plasma levels of the bioactive sphingolipid S1P are reduced in cystic fibrosis patients after lung transplantation depending on CFTR mutation. Journal of Cystic Fibrosis, 16, S41. https://doi.org/10.1016/S1569-1993(17)30294-1

Chicago Style (17th ed.) Citation

Halilbasic, E., et al. "EPS3.3 Plasma Levels of the Bioactive Sphingolipid S1P Are Reduced in Cystic Fibrosis Patients After Lung Transplantation Depending on CFTR Mutation." Journal of Cystic Fibrosis 16 (2017): S41. https://doi.org/10.1016/S1569-1993(17)30294-1.

MLA (9th ed.) Citation

Halilbasic, E., et al. "EPS3.3 Plasma Levels of the Bioactive Sphingolipid S1P Are Reduced in Cystic Fibrosis Patients After Lung Transplantation Depending on CFTR Mutation." Journal of Cystic Fibrosis, vol. 16, 2017, p. S41, https://doi.org/10.1016/S1569-1993(17)30294-1.